Nevro Corp. (NVRO) Event Oct. 28, 2022, 23:40 UTC 115 0 comments Nevro Corp. Website - Validate Account Comment Full text
Aptinyx Inc. (APTX) Event Oct. 28, 2022, 14:45 UTC 112 0 comments Aptinyx Inc. - Aptinyx Reports Third Quarter 2022 Financial Results and Highlights Comment Full text
Biomerica Inc. (BMRA) Event Oct. 28, 2022, 10:40 UTC 137 0 comments Biomerica, Inc. - Investor Presentation Comment Full text
Genmab (GMAB) Event Oct. 28, 2022, 06:46 UTC 114 0 comments Genmab Announces Submissions of Regulatory Applications for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL) and Diffuse Large B-Cell Lymphoma (DLBCL) Comment Full text
Mereo BioPharma (MREO) Event Oct. 28, 2022, 05:11 UTC 112 0 comments Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management Comment Full text
Avantor Inc. (AVTR) Event Oct. 28, 2022, 04:06 UTC 113 0 comments Avantor - Avantor Third Quarter Earnings Comment Full text
Avantor Inc. (AVTR) Event Oct. 28, 2022, 04:06 UTC 115 0 comments Avantor - Supplemental disclosures & Non-GAAP reconciliations Comment Full text
Assertio Holdings Inc. (ASRT) Event Oct. 27, 2022, 21:37 UTC 111 0 comments Assertio Holdings, Inc. - Third Quarter 2022 Financial Results Comment Full text
Edgewise Therapeutics Inc (EWTX) Event Oct. 27, 2022, 18:57 UTC 117 0 comments Edgewise Therapeutics - CureDuchenne Community Webinar: Edgewise Therapeutics – A Novel Approach To Protect Muscle In Duchenne & Becker Muscular Dystrophy Comment Full text
Inovio Pharmaceuticals Inc (INO) Event Oct. 27, 2022, 14:47 UTC 111 0 comments Inovio - 3Q 2022 Financial Results Conference Call Comment Full text